Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor-Reference-Cited by-同舟云学术

Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor

Published:2013-02 Issue:3 Volume:38 Page:168-183
ISSN:0743-5800
Container-title:Endocrine Research
language:en
Short-container-title:Endocrine Research

Author:

Yokono Masanori,Tahara Atsuo,Kurosaki Eiji,Yamajuku Daisuke,Kihara Rumi,Imamura Masakazu,Tomiyama Hiroshi,Kobayashi Yoshinori,Noda Atsushi,Shibasaki Masayuki

Publisher

Informa UK Limited

Subject

Endocrinology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07435800.2012.746364

Reference32 articles.

1. Diabetes and obesity: the twin epidemics

2. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

3. Sodium-Glucose Co-Transport Inhibitors

4. Type 2 diabetes: principles of pathogenesis and therapy

5. Antidiabetic drugs

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic approaches and clinical application of small-molecule inhibitors of sodium-dependent glucose transporters 2 for the treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry;2024-04

2. Guaiazulene and related compounds: A review of current perspective on biomedical applications;Life Sciences;2023-03

3. Evaluation of the Utility of Chimeric Mice with Humanized Livers for the Characterization and Profiling of the Metabolites of a Selective Inhibitor (YM543) of the Sodium-Glucose Cotransporter 2;Pharmaceutical Research;2017-02-13

4. Ramping Glucosuria for Management of Type 2 Diabetes Mellitus: An Emerging Cynosure;Medicinal Research Reviews;2014-03-14